NASDAQ:NEPH
Nephros Inc.
Nephros Inc.'s revenue grew 32.7% in fiscal 2025 to $18.8M while operating margin rose to 6.1%, its highest in 10 years. The diluted share count rose 3.5%.Summary generated from Nephros Inc.'s SEC filings. Latest annual report filed Mar 12, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$18.8M
Revenue growth+32.7%
Revenue, 5-yr CAGR+17.0%
Gross margin61.9%
Operating margin6.1%
Net margin6.4%
ROICn/a
Return on equity12.7%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+3.5%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 10 | 10 | 14 | 14 | 19 |
| Operating income | −3 | −4 | −2 | 0 | 1 |
| Net income | −4 | −7 | −2 | 0 | 1 |
| Free cash flow | −1 | −3 | 1 | −1 | n/a |
Recent filings
- 4Insider transaction report
Sep 16, 2026 - 4Insider transaction report
Sep 16, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 10, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KRegulation FD disclosure
Jun 15, 2026 - 8-KResults of operations and financial condition
May 7, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 7, 2026 - 10-K/AAmended annual report for the fiscal year ended Dec 31, 2025
Apr 30, 2026